Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |